Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Takayoshi Kurosawa"'
Autor:
Krishnan Ramanathan, Jin Nakahara, Takahiko Saida, Martin Merschhemke, Wendy Su, Takayoshi Kurosawa, Dieter A. Häring, Roman Willi, Ratnakar Pingili, Bernd C. Kieseier, Denis V Sazonov, Martin Zalesak, Jun-ichi Kira, Isao Tsumiyama
Publikováno v:
Multiple Sclerosis Journal. 28:1229-1238
Background: Ofatumumab, the first fully human anti-CD20 monoclonal antibody, has been developed as a treatment for relapsing multiple sclerosis (RMS) which can be self-administered at home. Objective: To investigate the efficacy and safety of ofatumu
Autor:
Akio Matsukage, Masakazu Yamaoka, Hirokazu Seto, Ta-i Horie, Takayoshi Kurosawa, Kengo Sakaguchi, Nobukazu Tanaka, Shonen Yoshida, Megumi Onoue, Yoshiyuki Mizushina, Hisaaki Yagi, Norikazu Aoyagi
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1308:256-262
The in vitro relationship between eukaryotic DNA polymerases and fatty acids was investigated. Some fatty acids strongly inhibited the activities of DNA polymerase alpha and/or beta in vitro. The kinetics of inhibition by linoleic acid showed that DN
Autor:
Takahiko Saida, Y. Itoyama, Qi Hao, Jun Ichi Kira, Seiji Kikuchi, Lixin Zhang-Auberson, Takayoshi Kurosawa, Dejun Tang, Kazuo Nagato
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 18(9)
Background: Fingolimod (FTY720) has previously shown clinical efficacy in phase II/III studies of predominantly Caucasian populations with multiple sclerosis (MS). Objectives: To report six-month efficacy and safety outcomes in Japanese patients with
Autor:
Takahiko Saida, Yasuto Itoyama, Seiji Kikuchi, Qi Hao, Takayoshi Kurosawa, Kengo Ueda, Lixin Zhang Auberson, Isao Tsumiyama, Kazuo Nagato, Jun-ichi Kira, Saida, Takahiko, Itoyama, Yasuto, Kikuchi, Seiji, Hao, Qi, Kurosawa, Takayoshi, Ueda, Kengo, Auberson, Lixin Zhang, Tsumiyama, Isao, Nagato, Kazuo, Kira, Jun-Ichi
Publikováno v:
BMC Neurology; 1/28/2017, Vol. 17, p1-10, 10p, 1 Diagram, 2 Charts, 3 Graphs
Autor:
Kengo Morohashi, Masakazu Yamaoka, Kengo Sakaguchi, Nobukazu Tanaka, Tadashi Horie, Takayuki Nara, Inoue Yasunori, Asayo Iseki, Hirokazu Seto, Takayoshi Kurosawa, Youichi Onomura, Hisaaki Yagi, Shonen Yoshida, Kiyoshi Takami, Megumi Onoue, Mitsuhiro Narusawa, Norikazu Aoyagi, Keiko Katsumi, Hana Ishida, Akio Matsukage, Yoshiyuki Mizushina
Publikováno v:
The Journal of Antibiotics. 49:491-492
Autor:
Jun-ichi Kira, Yasuto Itoyama, Seiji Kikuchi, Qi Hao, Takayoshi Kurosawa, Kazuo Nagato, Isao Tsumiyama, von Rosenstiel, Philipp, Lixin Zhang-Auberson, Takahiko Saida
Publikováno v:
BMC Neurology; 2014, Vol. 14 Issue 1, p1-22, 22p, 1 Diagram, 4 Charts, 2 Graphs
Autor:
Kazuo Nagato, Yasuto Itoyama, Philipp von Rosenstiel, Takayoshi Kurosawa, Takahiko Saida, Seiji Kikuchi, Lixin Zhang-Auberson, Jun Ichi Kira, Isao Tsumiyama, Qi Hao
Publikováno v:
BMC Neurology
Background A 6-month phase 2 study of fingolimod demonstrated efficacy and safety in Japanese patients with relapsing-remitting multiple sclerosis (MS). Here we report a 6-month observational extension that evaluated efficacy and safety in patients w
Autor:
Seiji Kikuchi, Takayoshi Kurosawa, Kazuo Nagato, Kengo Ueda, Takahiko Saida, Isao Tsumiyama, Lixin Zhang Auberson, Qi Hao, Yasuto Itoyama, Jun Ichi Kira
Publikováno v:
BMC Neurology
Background The low level of disease activity and manageable safety profile seen with fingolimod versus placebo in a 6-month, phase 2, randomized controlled trial in Japanese patients with relapsing multiple sclerosis (MS; ClinicalTrials.gov Identifie